How United Therapeutics Trounced Wall Street's Q3 Estimates [The Motley Fool]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: The Motley Fool
How United Therapeutics Trounced Wall Street's Q3 Estimates 09 hasn't been a great year so far for United Therapeutics ( NASDAQ:UTHR But United Therapeutics announced its third-quarter results before the market opened on Wednesday, spurring a nice jump in early trading. Here's what investors liked about the company's latest update. Image source: Getty Images. By the numbers United Therapeutics reported revenue in the third quarter of $0. million. This reflected a % decrease from the prior-year period revenue total of $.7 million. However, the number trounced the consensus revenue estimate from Wall Street analysts of $7. million. The company reported Q net income of $. million, or $.0 per share, based on generally accepted accounting principles ( GAAP Adjusted net income in the third quarter came in at $8. million, or $.8 per share. This was below the net income of $7.9 million, or $.98 per share, recorded in the same quarter of 08. However, it blew away the average analysts' adjusted
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference [Yahoo! Finance]Yahoo! Finance
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International ConferenceBusiness Wire
- United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder [Yahoo! Finance]Yahoo! Finance
UTHR
Earnings
- 2/21/24 - Beat
UTHR
Sec Filings
- 4/17/24 - Form 4
- 4/16/24 - Form 4
- 4/15/24 - Form 4
- UTHR's page on the SEC website